Literature DB >> 24948068

Involvement of PKA, PKC, CAMK-II and MEK1/2 in the acute antidepressant-like effect of creatine in mice.

Mauricio P Cunha1, Josiane Budni1, Francis L Pazini1, Ágatha Oliveira1, Julia M Rosa1, Mark W Lopes1, Rodrigo B Leal1, Ana Lúcia S Rodrigues2.   

Abstract

BACKGROUND: The aim of this study was to investigate the involvement of signaling pathways on the creatine antidepressant-like effect in the tail suspension test (TST) in mice.
METHODS: The TST was used to assess the antidepressant-like properties of creatine.
RESULTS: The anti-immobility effect of creatine (1mg/kg, p.o.) in the TST was blocked by i.c.v. pretreatment with H-89 (1μg/site, PKA inhibitor), KN-62 (1μg/site, CAMK-II inhibitor), chelerythrine (1μg/site, PKC inhibitor), U0126 (5μg/site, MEK1/2 inhibitor) or PD09058 (5μg/site, MEK1/2 inhibitor).
CONCLUSION: These results suggest that the antidepressant-like effect of creatine is dependent on PKA, CaMK-II, PKC and MEK 1/2 activation.
Copyright © 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Antidepressant; Creatine; Intracellular signaling; Kinases; Tail suspension test

Mesh:

Substances:

Year:  2014        PMID: 24948068     DOI: 10.1016/j.pharep.2014.03.004

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  14 in total

1.  The antidepressant-like effect of guanosine is dependent on GSK-3β inhibition and activation of MAPK/ERK and Nrf2/heme oxygenase-1 signaling pathways.

Authors:  Priscila B Rosa; Luis E B Bettio; Vivian B Neis; Morgana Moretti; Isabel Werle; Rodrigo B Leal; Ana Lúcia S Rodrigues
Journal:  Purinergic Signal       Date:  2019-11-25       Impact factor: 3.765

2.  Involvement of PI3K/Akt Signaling Pathway and Its Downstream Intracellular Targets in the Antidepressant-Like Effect of Creatine.

Authors:  Mauricio P Cunha; Josiane Budni; Fabiana K Ludka; Francis L Pazini; Julia Macedo Rosa; Ágatha Oliveira; Mark W Lopes; Carla I Tasca; Rodrigo B Leal; Ana Lúcia S Rodrigues
Journal:  Mol Neurobiol       Date:  2015-05-06       Impact factor: 5.590

3.  Creatine, similarly to ketamine, affords antidepressant-like effects in the tail suspension test via adenosine A₁ and A2A receptor activation.

Authors:  Mauricio P Cunha; Francis L Pazini; Julia M Rosa; Ana B Ramos-Hryb; Ágatha Oliveira; Manuella P Kaster; Ana Lúcia S Rodrigues
Journal:  Purinergic Signal       Date:  2015-02-22       Impact factor: 3.765

4.  Modulation of PKA, PKC, CAMKII, ERK 1/2 pathways is involved in the acute antidepressant-like effect of (octylseleno)-xylofuranoside (OSX) in mice.

Authors:  Lucimar M Pinto Brod; Mariana G Fronza; Jaqueline Pinto Vargas; Diogo S Lüdtke; César Augusto Brüning; Lucielli Savegnago
Journal:  Psychopharmacology (Berl)       Date:  2016-12-19       Impact factor: 4.530

5.  Creatine Prevents Corticosterone-Induced Reduction in Hippocampal Proliferation and Differentiation: Possible Implication for Its Antidepressant Effect.

Authors:  Francis L Pazini; Mauricio P Cunha; Dayane Azevedo; Julia M Rosa; André Colla; Jade de Oliveira; Ana B Ramos-Hryb; Patricia S Brocardo; Joana Gil-Mohapel; Ana Lúcia S Rodrigues
Journal:  Mol Neurobiol       Date:  2016-10-06       Impact factor: 5.590

6.  Signaling pathways underlying the antidepressant-like effect of inosine in mice.

Authors:  Filipe Marques Gonçalves; Vivian Binder Neis; Débora Kurrle Rieger; Mark William Lopes; Isabella A Heinrich; Ana Paula Costa; Ana Lúcia S Rodrigues; Manuella P Kaster; Rodrigo Bainy Leal
Journal:  Purinergic Signal       Date:  2016-12-13       Impact factor: 3.765

7.  Cyclic GMP-mediated memory enhancement in the object recognition test by inhibitors of phosphodiesterase-2 in mice.

Authors:  Lindsay M Lueptow; Chang-Guo Zhan; James M O'Donnell
Journal:  Psychopharmacology (Berl)       Date:  2015-11-02       Impact factor: 4.530

Review 8.  The Calcium/Calmodulin-Dependent Kinases II and IV as Therapeutic Targets in Neurodegenerative and Neuropsychiatric Disorders.

Authors:  Kinga Sałaciak; Aleksandra Koszałka; Elżbieta Żmudzka; Karolina Pytka
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

9.  Creatine target engagement with brain bioenergetics: a dose-ranging phosphorus-31 magnetic resonance spectroscopy study of adolescent females with SSRI-resistant depression.

Authors:  Douglas G Kondo; Lauren N Forrest; Xianfeng Shi; Young-Hoon Sung; Tracy L Hellem; Rebekah S Huber; Perry F Renshaw
Journal:  Amino Acids       Date:  2016-02-23       Impact factor: 3.520

Review 10.  Creatine for the Treatment of Depression.

Authors:  Brent M Kious; Douglas G Kondo; Perry F Renshaw
Journal:  Biomolecules       Date:  2019-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.